Drug intelligence / Profile preview

alpha-Mangostin

Development stage
Phase 2
Modality
Small Molecules
Administration
Topical
01

Overview

α-Mangostin is a natural xanthonoid compound primarily isolated from the pericarp (rind) of the mangosteen fruit (Garcinia mangostana L.). First identified in 1855, it has gained significant attention for its diverse pharmacological properties. ## Chemical Properties α-Mangostin is a yellow crystalline solid with the chemical formula C24H26O6 and a molar mass of 410.466 g/mol[9]. It has a melting point of 182°C and a density of 1.265 g/ml[9]. The compound is a xanthone derivative with a core xanthene-9-one structure[9]. ## Pharmacological Effects α-Mangostin demonstrates a remarkable range of biological activities: **Antioxidant and Anti-inflammatory** α-Mangostin is well-established as an antioxidant and anti-inflammatory agent[1][2]. These properties form the foundation for many of its therapeutic applications. **Antimicrobial Activity** The compound exhibits antibacterial, antifungal, and antiviral properties[4]. It has also shown promising antimalarial activity against both chloroquine-resistant and chloroquine-sensitive strains of Plasmodium falciparum[4]. **Anticancer Properties** α-Mangostin has demonstrated significant anticancer effects against various cancer types: - Inhibits growth of colon cancer cells with potency similar to 5-FU[2] - Induces cell cycle arrest and apoptosis through the intrinsic mitochondrial pathway[2][7] - Suppresses tumor formation in breast cancer models and reduces lymph node metastases[2] - Inhibits pancreatic cancer cell growth both in vitro and in xenograft models[7] **Metabolic Effects** Research suggests α-mangostin has beneficial effects on metabolic conditions: - Anti-obesity properties[5] - Hepatoprotective effects[5] - Antidiabetic activity[5] **Cardiovascular Protection** α-Mangostin has shown cardioprotective effects in various models: - Reduces total cholesterol and triglycerides in mouse models[5] - Decreases atherosclerotic lesion development[5] - Protects against doxorubicin-induced cardiotoxicity[5] **Neuroprotective Potential** Computational studies suggest α-mangostin may have applications in Alzheimer's disease treatment[1]. ## Mechanism of Action α-Mangostin's diverse effects stem from multiple mechanisms: - Cell cycle regulation: Induces G0/G1 and S phase arrest by affecting expression of cyclins, cdc2, and p27[2][7] - Apoptosis induction: Activates the intrinsic mitochondrial pathway[2][7] - Modulation of inflammatory pathways: Reduces pro-inflammatory cytokines like TNF-α, IL-1β, and IL-6[5] - Antioxidant activity: Scavenges free radicals and enhances endogenous antioxidant systems[1][5] ## Current Research and Applications Recent research has explored novel applications and delivery systems for α-mangostin, including a hydrogel film with chitosan alginate base for treating recurrent aphthous stomatitis (mouth ulcers)[10]. This formulation is currently undergoing clinical trials to evaluate its efficacy and safety. α-Mangostin continues to be investigated for its potential therapeutic applications across a wide range of conditions, from cancer and infectious diseases to metabolic disorders and inflammatory conditions.

Other names
alpha-mangostinβ-mangostinγ-mangostin
02

Targets

CDK1 (Cyclin-dependent kinase 1)Mitochondrial apoptotic pathway components

Beyond the preview

Go deeper on alpha-Mangostin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on alpha-Mangostin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call